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The GTPase Arf1 is the major regulator of vesicle
traffic at both the cis- and trans-Golgi. Arf1 is acti-
vated at the cis-Golgi by the guanine nucleotide ex-
change factor (GEF) GBF1 and at the trans-Golgi by
the related GEF BIG1 or its paralog, BIG2. The
trans-Golgi-specific targeting of BIG1 and BIG2 de-
pends on the Arf-like GTPase Arl1. We find that Arl1
binds to the dimerization and cyclophilin binding
(DCB) domain in BIG1 and report a crystal structure
of human Arl1 bound to this domain. Residues in
the DCB domain that bind Arl1 are required for
BIG1 to locate to the Golgi in vivo. DCB domain-
binding residues in Arl1 have a distinct conforma-
tion from those in known Arl1-effector complexes,
and this plasticity allows Arl1 to interact with dif-
ferent effectors of unrelated structure. The findings
provide structural insight into how Arf1 GEFs, and
hence active Arf1, achieve their correct subcellular
distribution.INTRODUCTION
Membrane trafficking depends on the Arf and Rab small GTPase
families (Donaldson and Jackson, 2011; Gillingham and Munro,
2007; Hutagalung and Novick, 2011). In the active (GTP-bound)
state, each GTPase binds a specific set of effectors that typically
includes vesicle coats, motor proteins, and vesicle tethering fac-
tors, as well as diverse regulators of organelle function. Each
active GTPase is typically present on only one organelle, and
so collectively, they determine the subcellular distribution of
numerous proteins. Thus, understanding how GTPases are
only activated in a particular location is critical to understanding
the logic of sub-cellular organization. For many GTPases, it has
been possible to identify specific guanine nucleotide exchange
factor (GEFs) that catalyze replacement of bound GDP with
GTP and so generate the active form of the GTPase. The organ-
elle-specific targeting of these GEFs is likely to be a major factor
in determining the distribution of active GTPases, but it remains
poorly understood for most Rabs and Arfs, especially as almost
all GEFs are themselves peripheral membrane proteins and
hence will require specific interactions with GTPases and otherThis is an open access article undmolecules for accurate membrane targeting (Barr, 2013; Miz-
uno-Yamasaki et al., 2012).
Of the small GTPases that regulate membrane traffic, Arf1 has
emerged as a master regulator of Golgi function (Jackson and
Bouvet, 2014; Pasqualato et al., 2002). In its GTP-bound state,
Arf1, and its close relatives, Arf3, Arf4, and Arf5, recruit the
COPI coat to the cis-Golgi to generate vesicles for transport
within the stack and back to the ER, while on the trans-Golgi,
Arf1 recruits the clathrin adaptor proteins AP-1 and AP-3 to
make vesicles directed to endosomes (Cherfils, 2014; Paczkow-
ski et al., 2015). Inhibition of Arf activity by drugs or mutation
causes disassembly of the Golgi apparatus and a complete
block in trafficking pathways (Klausner et al., 1992; Sa´enz
et al., 2009).
Arf1 activation on theGolgi is mediated by two distinct families
of GEFs, with mammals having GBF1 on the cis-Golgi, and two
closely related paralogs, BIG1 and BIG2, on the trans-Golgi (To-
gawa et al., 1999; Zhao et al., 2002). Although these large soluble
proteins are related over much of their 1,800-residue length,
both GBF1 and BIG1/2 have clear orthologs in all eukaryotic
kingdoms and so are thought to have diverged before the
appearance of the last eukaryotic common ancestor, indicating
that they have fundamentally distinct roles (Bui et al., 2009;
Wright et al., 2014).
Both GBF1 and BIG1/2 contain a central Sec7 domain that
catalyzes nucleotide exchange on Arf1 (Cherfils et al., 1998;
Mossessova et al., 1998). However, it remains unclear how the
proteins are targeted to different regions of the Golgi stack. In
addition to the 250-residue Sec7 domain, the GBF1 and
BIG1 proteins share five homology domains that are well
conserved in evolution (Bui et al., 2009; Mouratou et al., 2005).
Recent studies have suggested that other small GTPases bind
to these domains outside of the Sec7 domain to modulate the
location and extent of Arf1 activation. In particular, Drosophila
Arf-like GTPase Arl1 binds to the N-terminal region of the fly
ortholog of BIG1, and in mammalian cells, Arl1 is required for
the targeting of BIG1 to the Golgi (Christis and Munro, 2012).
In addition, the yeast BIG1 ortholog Sec7 binds to Arl1, and
also to Arf1 itself and two Rab family proteins Ypt1 and Ypt31,
and these interactions have been proposed to be involved in
the Golgi recruitment and activation of Sec7 (McDonold and
Fromme, 2014; Richardson et al., 2012). The interaction with
Arl1 is likely to be a key determinant of the trans-Golgi localiza-
tion of BIG1, as Arl1 specifically localizes to the trans-Golgi in
both yeast and mammalian cells (Lu et al., 2001). Moreover,
Arl1 mediates Golgi recruitment of several coil-coiled proteinsCell Reports 16, 839–850, July 19, 2016 ª 2016 The Authors. 839
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Figure 1. BIG1 Binds to Arl1 via the DCB
Domain
(A) Domain structure of the BIG family of Arf-GEFs:
DCB (dimerization and cyclophilin binding), HUS
(homology upstream of Sec7), andHDS (homology
downstream of Sec7).
(B) Coomassie-blue stained protein gel of binding
assays between His6-tagged BIG1 fragments and
GST-Arl1DN14. Input lanes contain 10% of the
material used for pull-downs. Fragments contain-
ing the DCBBIG1 domain bound preferentially to
GST-Arl1 DN14 loaded with the GTP-analog GMP-
PNP (red arrows).
(C) Pull-downs assay similar to (B) but with a BIG2
N-terminal fragment (1–216) or with a GFB1
N-terminal fragment (1–566).
See also Figure S1.that tether incoming vesicles, suggesting that Arl1 could be a
master regulator of trans-Golgi membrane traffic (Panic et al.,
2003b; Wong and Munro, 2014).
Arl1 binds to the N-terminal 559 residues of BIG1, a region that
is a sufficient for Golgi targeting and that contains two predicted
domains: the DCB (dimerization and cyclophilin binding) and the
HUS (homology upstream of Sec7) domains (Bui et al., 2009;
Mouratou et al., 2005; Christis and Munro, 2012; Mansour
et al., 1999). The association of a missense mutation in the
BIG2 DCB domain with a case of a familial neurodevelopmental
disorder (Sheen et al., 2004) and the fact that DCB in GBF1 is
needed for picornavirus replication (Belov et al., 2010) under-
score the importance of the DCB domain.
To gain insight into how Arl1 regulates Arf1 activation at the
trans-Golgi, we have mapped the Arl1 binding site on BIG1 to
the N-terminal DCB domain and then determined its structure
in a complex with Arl1GTP at a resolution of 2.3 A˚. Mutagenesis
shows that interaction between the DCB domain and Arl1 is a
major determinant of BIG1’s ability to recognize the trans-Golgi.
The Arl1 binding surface on the DCBdomain consists of four par-
allel a helices, a structure unrelated to any known Arl1 effectors,
and the Arl1 residues in the binding interface show a conforma-
tional plasticity that allows it to specifically recognize structurally
unrelated effectors.
RESULTS
Identification of theDCBDomain as theArl1 Binding Site
The N-terminal part of the Drosophila BIG1 homolog Sec71
binds directly to GTP-bound Arl1, and the analogous region of
human BIG1 (1–559) is sufficient for Golgi targeting in mamma-
lian cells (Christis and Munro, 2012; Mansour et al., 1999). This
region contains two of the six conserved domains of the proteins,
the DCB and HUS domains (Figure 1A). To map the Arl1 binding840 Cell Reports 16, 839–850, July 19, 2016region, N-terminal fragments of BIG1
were assayed for binding to human
GST-Arl1. The DCB domain (DCBBIG1
[1–228]) bound to Arl1GTP, while the HUS
domain did not, with a similar result ob-
tained with the Drosophila proteins (Fig-ure 1B; data not shown). The DCB domain could also capture
endogenous Arl1 from mammalian cell lysates in a GTP-depen-
dent manner (Figure S1A).
The DCBdomain was first described in GNOM, anArabidopsis
ortholog of GBF1 (Grebe et al., 2000). Related DCB domains in
mammalian GBF1 and BIG1 were found based on sequence
conservation between different species (Bui et al., 2009; Moura-
tou et al., 2005). The DCB domain in human BIG1 was originally
annotated as residues 70–228; however, we found that while the
N terminus could be truncated to residue 23 and still interact with
Arl1GTP, larger N-terminal truncations to 51 or 61 did not bind,
indicating that the actual domain is slightly larger (Figure S1B).
Arl1GTP shows specificity for DCB domains from proteins of the
BIG family, as it also binds to the related region from BIG2, but
not to the equivalent part of human GBF1 (Figure 1C).
Crystallization of aComplex of Arl1GTP Bound to theDCB
Domain
To elucidate the nature of the DCB domain and the basis of its
interaction with Arl1, the first 228 residues of human BIG1
(DCBBIG1) was coexpressed in Escherichia coli with human
Arl1 lacking residues 1–14. These residues form an amphipathic
helix that becomes fully exposed upon GTP binding, and its
removal has been found to be necessary for the crystallization
of GTP-bound forms of Arf-family proteins (Panic et al., 2003a;
Shiba et al., 2003; Wu et al., 2004). As in previous studies, the
mutation Q71L was used to ensure that the protein remained in
the GTP-bound form.
This initial complex crystallized in space group P312, with unit
cell dimensions a,b = 96.5 A˚ and c = 201.1 A˚, but the collected
data were not of sufficient quality to solve the structure. Inspec-
tion of alignments of BIG1 orthologs from diverse species re-
vealed a region between residues 51 and 71 that is poorly
conserved and predicted to be disordered (Figure 2, highlighted
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Figure 2. Alignment of the N-Terminal Region of the BIG and GBF Families of Arf-GEFs
Alignment of sequences of BIGs and GBFs from diverse species (Hs, Homo sapiens; Mm, Mus musculus; Dr, Danio rerio; Dm, Drosophila melanogaster; Dd,
Dictyostelium discoideum; At, Arabidopsis thaliana; Sc: Saccharomyces cerevisiae; Kl, Kluyveromyces lactis; Cr, Chlamydomonas reinhardtii; Tv, Trichomonas
vaginalis). Metazoan names are blue; plants, protists, and fungi are green, orange, and gray, respectively. Conserved residues are colored according to the
BLOSSUM62 matrix (threshold for visibility is 10%). Deletions (red dashes) correspond to Ser18-Gly217 in S. cerevisiae Sec7, Arg17-Met82 in K. lactis Sec7,
Thr39-Asn65 in Gea1, Ser36-Asn62 in Gea2, Ser40-Asn66 in K. lactisGea, and Pro36-Arg51 in C. reinhardtiiGea. Also indicated are conserved residues specific
to the BIG family (red dot above) or to theGBF family (blue dot below). Residues 51–71 (inclusive) in human BIG1 deleted for crystallization are green. Key residues
in the Arl1GTP/DCBBIG1 interaction (red bold) and the DCB-DCB interface (black bold) are shown along with the secondary structure of the DCBBIG1 domain.
Orange bold type indicates Ser402 in S. cerevisiae Sec7, mutation of which to Leu results in a temperature-sensitive phenotype (Jones et al., 1999), and Glu209 in
human BIG2, mutation of which to Lys causes paraventricular heterotopia (Sheen et al., 2004).
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Figure 3. Structure of the Human Arl1GTP /
DCBD51–71 Complex
(A) Two views of the Arl1Q71L-GTP/Mg2+/ DCBD51–71
complex. The DCBD51–71 domain (green) is formed
by eight a helices and binds Arl1 via helices 1, 4, 6,
and 8. Arl1 is blue, with switch 1 in red, the inter-
switch in pale green, and switch 2 in orange. The
GTP molecule is shown as sticks, and Mg2+ as a
sphere of green dots.
(B) The Arl1-DCB domain interface. DCB a1 and a4
abut switch 1 and the interswitch of Arl1, while a6
and a8 abut the interswitch and switch 2. Side
chains of residues involved in the interaction are
shown as sticks. The DCB domain residues are
green with black labels. The Arl1 switch 1, inter-
switch, and switch 2 residues are colored as in (A).
Residue contacts based on hydrogen bonds with
atomic distance below 3A˚ are indicated with black
dashed lines.
See also Figures S2 and S3 and Table S1.in green). Deletion of this putative unstructured loop did not
affect the interaction between Arl1GTP and DCBBIG1 domain (Fig-
ure S1) but improved the quality of the crystals.
This modified complex Arl1Q71L-GTP/DCBD51–71 crystallized
in space group C2, with unit cell dimensions a = 84.2 A˚,
b = 50.7 A˚, and c = 103.8 A˚, with one complex per asymmetric
unit. The X-ray structure was determined at 2.3 A˚ resolution
(Table S1) and solved by molecular replacement using Arl1
from the Arl1GTP:GRIP domain complex and the N-terminal
HEAT (Huntingtin, elongation factor 3, protein phosphatase
2A, and TOR1)-like repeat domain of the Drosophila mela-
nogaster microtubule regulatory protein MAST/Orbit that was
predicted to be distantly related to the DCB domain by HHpred
(De la Mora-Rey et al., 2013; Hildebrand et al., 2009; Panic
et al., 2003a). The final model includes all of the residues of
the DCBD51–71 domain with the exception of three residues
(71–73) adjacent to the region that was deleted (Figures 3A
and S2).
Overall Structure of Arl1Q71L-GTP/DCBD51–71 Domain
Complex
The DCB domain is comprised of eight antiparallel a helices
arranged a twisted array where helices 1, 4, and 6 are
packed against helices 2, 3, 5, and 7. Helices 3–8 form a right-
handed helical solenoid similar to a HEAT repeat domain (Fig-
ure 3A). The beginning of a helix 8 is also facing helix 7, but its
C-terminal half protrudes out of the rest of structure. The
arrangement of the helices creates two different surfaces. One
formed by helices 1, 4, 6, and 8 is slightly convex and interacts
with Arl1Q71L-GTP, and the other formed by helices 2, 3, 5, and842 Cell Reports 16, 839–850, July 19, 20167 is slightly concave. The region removed
to aid crystallization (51–71) connects
helices 2 and 3, and the remaining link be-
tween these two a helices is not fully or-
dered in our model (residues 72 and 73).
As expected, the Arl1Q71L-GTP exhibits
the typical fold of small GTPases, con-taining a six-stranded b sheet surrounded by five a helices (Han-
zal-Bayer et al., 2002).
The Interaction Interface between Arl1 and the DCB
Domain
The interface between Arl1GTP and DCBD51–71 has a total surface
area of 1,509 A˚2. Arl1GTP engages with the DCB domain mainly
through switch 1 and switch 2, with some additional residues
from the interswitch. This accounts for the GTP-dependency of
binding as these regions of Arf family G proteins undergo large
conformational changes upon GTP-binding (Pasqualato et al.,
2002). DCB domain a helices 1 and 4 form most of the switch 1
interactions and a helices 6 and 8 interact mainly with switch 2
(Figure 3B).
The surface on Arl1GTP that interacts with the DCB domain
is composed mainly of hydrophobic amino acids (Glu41,
Thr44, Ile46, Ile49, Phe51, Glu54, Trp66, Tyr77, Cys80, and
Asn84). Of these, those from switch 1 and the interswitch
are present in many Arf family members with, for instance,
all being in conserved in Arf1 (Figure S3). However, from
switch 2, Tyr77 is present in only a few other Arls, and Cys80
is unique to Arl1 (Pasqualato et al., 2002). The region of the
DCB domain that interacts with Arl1GTP comprises twenty
residues that are within 3.7 A˚ of the surface of Arl1. The closest,
ie those within 3.3 A˚ or less, are the hydrophobic residues
Ala108, Leu149, Leu156, Ile189, and the polar and charged
residues Arg14, Lys105, Tyr109, Thr193, Lys195, Thr197,
Gln200, and Asn203 (Figure 3B). Most of these residues
are conserved in DCB domains across species (Figures S3A
and S3B).
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Figure 4. Mutational Analysis of Residues in
the Arl1 Binding Interface
(A) Binding assay to determine the effect of DCB
mutations on binding to Arl1. The indicated ver-
sions of His6-DCB
BIG1 were mixed with GMP-PNP
loaded GST-Arl1DN14, and material bound to Ni-
NTA beads was analyzed by SDS-PAGE and
Coomassie staining.
(B) Determination of the dissociation constant of
the Arl1GTP/DCBBIG1 complex by fluorescence
anisotropy. NT-495-labeled Arl1GTP was mixed
with wild-type or DCBBIG1 mutants. Curves fitted
to a 1:1 binding model are shown, along with the
calculated Kd.
(C) Confocal micrographs of HeLa cells expressing
hemagglutinin (HA)-tagged forms of BIG11–559 or
full-length BIG1. After fixation, cells were stained
for the H -tag and the Golgi marker GM130. Scale
bars, 15 mm.
See also Figure S4.Comparison of GBF1 and BIG1 orthologs reveals four
conserved regions: the first two map to a helices 1 and 2 in the
DCBBIG1 structure, the third one is formed by a helices 3
and 4, and the last one includes the helices 6, 7 and 8. Some
of these conserved residues are shared among BIG and GBF
families, such as Lys105, Leu155, and Ala194 while others are
specific to one of the two classes, such as Cys102, Leu156,
and Gln200 in BIG1 (Figure 2). Close inspection of the structure
shows that one of these BIG-specific residues, Gln200, makes
extensive hydrophobic interactions with residue Tyr77 in switch
2 of Arl1, a residue that is involved in binding other Arl1 effectors,
as discussed below.
Structure-Based Mutational Analysis of Golgi
Membrane Recruitment
Next, we investigatedwhether the residues that form the interac-
tion surface between Arl1GTP and the DCB domain are actually
important for BIG1’s ability to bind to Arl1-GTP in vitro and to
localize to the Golgi in vivo. Residues located in the conserved
regions of DCB a helices 4, 6, and 8 were found to be needed
for binding in vitro. Thus, Lys105Asp or Tyr109Lys substitutions
in Arl1-binding residues in a helix 4 prevented copurification of
recombinant DCBBIG1 with Arl1GTP (Figure 4A). Similar results
were obtained when Leu156 (a helix 6) or Gln200 (a helix 8)Cwere replaced by Asp or Glu, respec-
tively. These mutations did not affect the
folding and thermal stability of the DCB
domain (Figure S4A). Mutation of other
residues located in the three conserved
helices 4, 6, and 8 caused weaker but
reproducible effects on Arl1 binding
(Figure S4B). Fluorescence anisotropy
measurements of the Arl1GTP/DCBBIG1
complex in solution gave a Kd for bind-
ing of 26 ± 5 mM, and the Lys105Asp
and Gln200Glu mutations increased the
Kd by at least a factor of 5, withLeu156Asp having a somewhat smaller effect (Figures 4B,
S4B, and S4C).
We next investigated the effect of these mutations on the abil-
ity of BIG1 to bind to the Golgi in vivo. Themutations Lys105Asp,
Leu156Asp, and Gln200Glu that all had a strong effect on bind-
ing in vitro also caused both full-length BIG1 and BIG11–559 to re-
localize to the cytoplasm (Figure 4C). Protein blots of cell lysates
confirmed that the mislocalization of the mutants is not due to
protein degradation, and thus the DCB-Arl1 interaction is amajor
determinant of BIG1 recruitment to the Golgi (Figure S4D).
DCB Domain Dimerization Interface
The original description of the DCB domain reported that the
related region of the plant GBF1 ortholog, GNOM, could dimerize
in a yeast two-hybrid assay (Grebe et al., 2000). In addition a
yeast two-hybrid screen revealed cyclophilin Cyp5 as a putative
interaction partner, although Cyp5 was found to have a leader
peptide and subsequently shown to be in the ER lumen, making
it very unlikely that the two proteins interact in vivo (Anders et al.,
2008). However, the DCB domains of human BIG1 and BIG2
were also found to form dimers, as determined by both gel filtra-
tion and analytical ultracentrifugation (Ramaen et al., 2007). In
the crystal two Arl1-GTP/DCBD51–71 complexes related by two-
fold crystallographic symmetry have an extensive interfaceell Reports 16, 839–850, July 19, 2016 843
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units of the Arl1GTP/DCBD51–71 complex. The two
DCB domains (green and turquoise) interact
through helices a7 and a8. Each DCB domain
binds to a molecule of Arl1 (blue, with switch 1 in
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The expected size for a MBP-DCBBIG1 monomer is
69 kDa, while the average mass for the wild-type
protein is 129 kDa, R176E mutant is 110 kDa,
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(D) Confocal micrographs of live HeLa cells ex-
pressing the N-terminal GFP-tagged DCB do-
mains from BIG1 or GBF1 as indicated. An
RFP-tagged form of the golgin CASP was used as
a Golgi marker (Gillingham et al., 2002). The
R176E/Y182K mutant is expressed at slightly
higher levels than the wild-type protein for reasons
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at comparable expression levels, the mutant ap-
peared indistinguishable from wild-type, but we
show representative cells where the expression
levels, and hence cytoplasmic staining, are higher.
Scale bars, 5 mm.(866.9 A˚2) and suggest a dimer of heterodimers (Figure 5A). The
dimerization interface comprises helices a7 and a8 that are rich
in hydrophobic and basic residues. The hydroxyl group of Tyr182
is hydrogen bonded to the hydroxyl group of Tyr182 in the adja-
cent symmetric chain, while Arg176 is hydrogen bonded to
Asn203 in the symmetric molecule (Figure 5B). The arrangement
of the Arl1 proteins in the dimer would allow their N-terminal
amphipathic helices to interact simultaneously with the lipid
bilayer, an arrangement also seen in the two other Arl1 effectors
whose structures have been solved (Nakamura et al., 2012;
Panic et al., 2003a; Wu et al., 2004). However, although mutation
of Arg176 and Tyr182 disrupted dimerization of the isolated
domain in solution, this did not affect Golgi targeting in vivo,
and so the physiological significance of this dimer is unclear (Fig-
ures 5C and 5D). Interestingly, a recent study of human GBF1
reported that mutations that disrupt dimerization in vitro had
no effect on localization or activity (Bhatt et al., 2016). It may
be that if the dimer exists in vivo it represents an inactive or
non-membrane-bound form of the GEF.
Interaction between Arl1 and DCB Differs from Other
Arl1 Effectors
We next compared the structure of this complex to those of the
two known complexes involving other Arl1 effectors. These are
the GRIP (golgin-97, RanBP2a, Imh1p, and p230/golgin-245)
domain from the C terminus of golgin-245, one of several
GRIP-domain-containing coiled-coil proteins that can capture
endosome-derived vesicles, and Arfaptin-2, a BAR (Bin-Amphi-844 Cell Reports 16, 839–850, July 19, 2016physin-Rvs) domain protein that is localized to the trans-Golgi
but whose function is unclear (Man et al., 2011; Nakamura
et al., 2012; Panic et al., 2003a). The three effectors are
completely unrelated in structure, but all three bind Arl1 via the
hydrophobic interaction surface formed by the switch regions
(Figures 6A and 6B). The GRIPGolgin245 domain interacts mainly
with Arl1 switch 2 and the hydrophobic pocket (Figures 6C and
S5), but there is another hydrophobic groove formed by switch 1
and the interswitch that makes extensive contacts with the
DCBBIG1 and the BARArfaptin2 domains (Figures 6A, 6D, and
S5). Few residues outside the switch regions in Arl1 contribute
to the interactions, apart from Asn84, which interacts with
Ile188 in DCBBIG1; and Arg19, which interacts with Ile189 in
DCBBIG1 and with Asp220 in the a2 chain of Arfaptin-2 (Naka-
mura et al., 2012). The major role of the switch regions in the in-
teractions accounts for the specificity of all three effectors for the
GTP-bound form of Arl1.
Khan and Me´ne´trey have proposed a classification scheme
to highlight properties shared by domains that bind to Arf/
Rab GTPases (Khan and Me´ne´trey, 2013). Many of these do-
mains adopt an ‘‘all-a-helical’’ conformation ranging from
coiled-coil structures to a-helical bundles or aspects of both.
These domains usually interact with the GTPase via two
helices that pack against the switch-interswitch junction. In
the case of the DCB domain, the surface of interaction is
actually formed by four parallel helices, two of which interact
with Arl1’s switch 2 with the other two interacting mainly with
switch 1.
The ability of Arl1 to recognize three very different effectors rai-
ses the question of how it can maintain selectivity for its own ef-
fectors over those of related GTPases while at the same time be-
ingpromiscuous in the interactions formedby its effector-binding
interface. Selectivity can be explained by the sequences of the
switch regions themselves, and in particular switch 2, which is
involved in effector binding in all three complexes and has resi-
dues conserved in few, if any, other members of the Arf family.
As for the structural plasticity that underlies the binding of
several distinct effectors by the same GTPase, examination of
other Arf:effector complexes revealed that Arf proteins generally
maintain a rigid core structure independent of their binding part-
ners (KhanandMe´ne´trey, 2013). Thus, themajor site of conforma-
tional variability is the interaction interface itself. At the center of
the interaction surface is a common hydrophobic area (CHA) of
480 A˚ (Figure 6B) (Khan and Me´ne´trey, 2013; O’Neal et al.,
2005). A feature of the CHA is the aromatic triad Phe51, Trp66,
and Tyr81 that is highly conserved in Arfs and Rabs and found
in somecases toundergo rotational isomerization toallowbinding
to different effectors (Khan and Me´ne´trey, 2013; Recacha et al.,
2009). However, this does not appear to be the case for Arl,1 as
these three residues vary little among the three complexes.
The other conserved feature of the CHA is the hydrophobic
pocket located at the interface between switch 1, the inter-
switch, and switch 2, and in Arl1 comprising nine residues:
Ile49 and Gly50 from switch 1; Phe51, Val53, and Trp66 from
the interswitch; and Ile74, Tyr77, and Tyr81 from switch 2 (Fig-
ure 6B). Comparison of the three structures reveals that the
largest differences in the interfacial side chains are in the resi-
dues in switch 1 that flank the hydrophobic pocket (Figure 6C).
In the case of the GRIP domain, Tyr2177 projects into the hydro-
phobic pocket to hydrogenbondwith Tyr81 fromArl1 (Figure 6D).
Likewise, the Arfaptin-2 BAR domain also projects Phe285 in-
side the hydrophobic pocket. In both cases, the carbonyl group
of Arl1 Ile49 is facing out of the hydrophobic pocket (Figure 6D).
In contrast, in the Arl1GTP/DCBD51–71 complex, the carbonyl
group of Arl1 Ile49 remains buried inside the rim of the hydropho-
bic pocket (Figure 6D). The switch between these two conforma-
tions is possible because of the adjacent Gly50 residue. For the
DCB interaction, the Arl1 hydrophobic pocket is locked by
Gln200 from the DCB domain, which does not protrude deeply
into the pocket, but its amide group is hydrogen bonded to the
oxygen from the carbonyl of Ile49, and the phenyl group of
Tyr77 is rotated by 70 (relative to that in the GRIP domain com-
plex) so as to face the side chain of Gln200 (Figure 6D). Previous
studies on the GTPase Arl2 have also found two distinct orienta-
tions for the carbonyl before Gly50 in complexes with two
different effectors (Chavrier and Me´ne´trey, 2010; Hanzal-Bayer
et al., 2002; Zhang et al., 2009). Indeed, this glycine residue is
conserved in all Arf family members except Sar1 and in the
Rab and Ran families as well, suggesting that it is key contributor
to the structural plasticity that allows these GTPases to bind to
multiple effectors.
DISCUSSION
Our work has provided structural insight into the regions that
flank the central Sec7 catalytic domain of the two major classesof Golgi Arf GEF. In addition, it shows how Arl1 interacts with
BIG1 via the DCB domain. Although some of the conserved res-
idues in the BIG1 DCB domain are specific to the BIG family, this
DCB region is also present in the GBF1 family and in the more
distantly related MON2 and BIG3 proteins that lack GEF activity
and are of unknown function (Efe et al., 2005; Gillingham et al.,
2006; Li et al., 2014). Thus, it seems possible that the DCB
domain of these other proteins will also contribute to membrane
recruitment by binding other small GTPases. Indeed, we found
that the DCB domain of human GBF1 is sufficient for Golgi tar-
geting (Figure 5D). This DCB domain does not bind Ar1l, consis-
tent with GBF1 being on the cis-Golgi (Figure 1C). The first 380
residues of GBF1 that include the DCB domain have been re-
ported to interact with Rab1B (Monetta et al., 2007), but we
were not able to detect an interaction between GBF1 fragments
DCB(1–215) or DCB-HUS(1–566) and either Rab1A or Rab1B (A.G.,
unpublished data).
Another notable feature of the DCB domain is that it has a
HEAT repeat structure. Strikingly, the structural-based homol-
ogy detection program HHpred (Hildebrand et al., 2009) not
only detects that DCB is related to known HEAT repeat proteins
but also predicts a similar relationship for large sections of the
rest of the regions of BIG1 and GBF1 that flank the Sec7 domain.
Thus, it seems quite possible that these proteins are elongated
molecules consisting of the Sec7 domain flanked by HEAT-
repeat-based solenoids that serve as flexible scaffolds for inter-
action with membrane landmarks and regulatory molecules
(Andrade et al., 2001). Given this likely elongated structure for
these large proteins, it seems improbable that Arl1 is the only
protein that interacts with BIG1 (Wright et al., 2014). Indeed,
studies on yeast Sec7 have shown an interaction not only with
Arl1 but also with Arf1, Ypt1, and Ypt31 (McDonold and Fromme,
2014). TheDCBdomain of yeast Sec7 also appears important for
Golgi targeting, as the yeast sec7-1 allele, a thermosensitive
mutant that carries the substitution S402L in the DCB domain
(Figure 2), results in mislocalization of GFP-Sec7-1 at the restric-
tive temperature (Richardson et al., 2012). Sec7’s interaction
with Arf1 may provide a positive feedback loop to increase
recruitment, but it seems unlikely to have a role in specificity
as Arf1-GTP is also abundant on the cis-Golgi. The interactions
with Ypt1 and in particular Ypt31 appear to activate exchange
activity by relieving inhibitory interactions following membrane
binding (McDonold and Fromme, 2014). The relevance of these
findings to mammalian cells is unclear, and indeed, in mammals,
the orthologs of Ypt1 (Rab1) and Ypt31 (Rab11) are on the cis-
Golgi and recycling endosomes, respectively. Nonetheless,
although our results demonstrate that, in mammals, Ar1l is crit-
ical for bringing BIG1 to the Golgi, the rest of BIG1 could help
to stabilize membrane binding, regulate GEF activity, or even
scaffold interactions with other proteins once BIG1 is membrane
associated.
In addition to the findings described here, a recent paper has
reported the structure of an N-terminal region of Sec7 from the
thermophilic filamentous fungus Thielavia terrestris that contains
both the DCB and adjacent HUS domain (Richardson et al.,
2016). The overall fold of the DCB domain is the same as that
we find for human BIG1, and the HUS domain is confirmed to
comprise a HEAT-repeat solenoid as predicted by HHPREDCell Reports 16, 839–850, July 19, 2016 845
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0
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the DCB-HUS region from Thielavia terrestris Sec7
(blue, PDB: ID 5HAS).
(B) Two views of an alignment of human BIG1
DCBD51–71 and the DCBdomain from the DCB-HUS
T. terrestris Sec7 structure, with coloring as in (A).
The root-mean-square deviation is 8.4 A˚, with this
relatively high value primarily reflecting differences
in the conformation of the loop between a helices 4
and 5 and in the tilt of a helix 8.(Figures 7A and 7B). Two interesting features emerge from
comparing the two studies. First, although Sec7 from the
budding yeast Saccharomyces cerevisiae is reported to bind
Arl1, the DCB-HUS region of the protein does not appear to
bind Arl1 (Richardson et al., 2016). However, although the 20 res-
idues that form the Arl1 interface in human BIG1 are very well
conserved in metazoans (eg 18 are identical in Drosophila with
two conservative changes), they are not well conserved in yeast
(only six are identical in S. cerevisiae Sec7). Thus, it appears that
in yeasts Arl1 binds to a region of the protein other than the DCB
domain recognized inmetazoans. The second interesting feature
revealed by comparing the structures is that in the DCB-HUS
structure, the HUS domain covers the region on the DCB domain
that forms the DCB homo-dimer interface reported here (Fig-
ure 7B). This raises the possibility that the ability of the isolated
DCB domain to form a dimer in vitro could simply be a conse-
quence of removing the HUS domain. However, it is striking
that the junction between the DCB and HUS domains involves(B) Arl1GTP ribbon diagram/surface representation. Switch 1 is red, interswitch is pale green, and switch 2 is o
common hydrophobic area (CHA), with the hydrophobic pocket in red. The GTP molecule is shown as stic
(C) Alignment of the Arl1 switch regions from the Arl1GTP/DCB D51–71 and Arl1GTP/GRIPGolgin245 complexes b
0.538 A˚). Switch 1 is red or pink, the interswitch celadon or grass green, and switch 2 orange or yellow
structures, respectively. Key residues of the CHA are indicated.
(D) The Arl1 hydrophobic pocket in the DCBBIG1, GRIPGolgin245, and BARArfaptin2 complexes. Arl1 residues I49
shown is a single residue from each of the three different Arl1 effectors that projects into the pocket (bright gre
(rectangle). Angles are similar in the three structures, but their orientation in the DCB structure is reversed, re
group, as indicated below each view.
See also Figures S5.
Ctwo helices that, unlike the rest, project
out of the solenoid. Moreover, in most
species, these helices are connected by
a linker of 100 residues that is poorly
conserved and predicted to be disor-
dered. This raises the possibility that under
some circumstances, the DCB and HUS
domains separate to allow the DCB
domain to form a homodimeric interaction
or to even pair with the HUS domain on a
second molecule as has been suggested
previously (Ramaen et al., 2007). Indeed,
although the T. terrestris DCB-HUS frag-
ment that was crystalized is monomericin solution, the equivalent region of S. cerevisiae Sec7 is dimeric
(Richardson et al., 2016).
A full understanding of the organization of these Arf GEFs and
how this relates to their activity will probably require the structure
of a complete protein. Nonetheless, our structural and mutagen-
esis data show that Arl1 is a major determinant for recruiting
BIG1 to the trans-Golgi, and they identify the DCB domain as a
small GTPase binding region for at least the mammalian large
Arf GEFs. These data thus open the way to a structurally
informed dissection of the targeting and regulation of these
key components of membrane traffic.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification
Human Arl1 (UniProt P40616, residues 15–181), carrying the Q71L mutation,
and human BIG1 (UniProt Q9Y6D6) fragment DCBBIG1 (residues 1–228) were
co-expressed from pOPTC (Panic et al., 2003a) in BL21-(DE3)-RIPL as
GST-Arl1Q71L and His6-DCB
BIG1. The same strategy was followed for therange. The dark gray part of the surface indicates the
ks.
ased on Ca position (root-mean-square deviation of
for the Arl1GTP/DCBBIG1 and Arl1GTP/GRIPGolgin245
, G50, F51, Y77, and Y81 are shown as sticks. Also
en). Values of dihedral angles for Ile49 are indicated
sulting in a different position of the I49 carbonyl (C0)
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coexpression of Arl1Q71L and the BIG1 fragment DCBD51–71 (residues 1–228
with a deletion of 21 residues [51–71 inclusive]). Cells expressing either
Arl1Q71L/DCBBIG1 or Arl1Q71L/DCBD51–71 were grown at 37C until optical den-
sity 600 (OD600)1 and inducedwith 0.2 mM IPTG at 15C for 16 hr. Cells were
pelleted, resuspended in buffer A (50 mM Tris-HCl [pH 7.5], 100 mM NaCl,
5 mM MgCl2, 1 mM DTT, and 0.2 mM GTP) and lysed with an Emulsiflex-C3
at 15,000 psi at 4C. The cell lysate was cleared by centrifugation at
16,000 3 g for 30 min at 4C and mixed with glutathione-Sepharose beads
(GE Healthcare). After three washes of ten bed volumes, resin-bound material
was released with 0.08 mg TEV protease per 10 mg complex for 12 hr at 4C.
The Arl1Q71L/DCB complexes were further purified by gel filtration on a Super-
dex 75 16/60 column equilibrated in buffer B (20mMTris-HCl [pH 7.5], 100mM
NaCl, 1mMMgCl2, 1mMDTT, and 0.01mMGTP). After elution, fractions were
concentrated to 12–14 mg/ml and snap frozen in liquid nitrogen.
Crystallization
Initial crystals of Arl1Q71L/DCBBIG1 and Arl1Q71L/ DCBD51-71 complexes were
obtained by vapor diffusion in sitting drop at 18C. Drops weremade bymixing
50 nl protein solution and 50 nl reservoir solution (Arl1Q71L/DCBBIG1: 17%–22%
[w/v] PEG4000, 100 mM Tris-HCl 8.5, 150 mM Li2SO4; Arl1
Q71L/ DCBD51–71:
10% [w/v] PEG8000/PEG1000, 100 mM Tris-OAc [pH 8.5], and 0.1–0.2 mM
NaOAc). Microseeding was used to increase crystal nucleation. Crystals
were harvested and cryo-cooled in reservoir solution supplemented with
25% (w/v) PEG4000 for Arl1Q71L/DCBBIG1 or with 20% (v/v) glycerol in the
case of Arl1Q71L/ DCBD51–71.
Data Collection, Phasing, and Model Refinement
Diffraction data were collected at 100C at beamlines I03 and I04 at the Dia-
mond Light Source (STFC-UK). Crystallographic data were processed with
XDS (Kabsch, 2010) or iMOSFLM (Powell et al., 2013) and reduced and scaled
using Pointless and Aimless from the CCP4 suite (Winn et al., 2011). Crystal
structures were solved by molecular replacement using Phaser (McCoy
et al., 2007). Search models were Arl1Q71L-GTP (PDB: 1UPT) (Panic et al.,
2003a) and the N-terminal region of MAST/Orbit (PDB: 4G3A) (De la Mora-
Rey et al., 2013). Model rebuilding was done with Coot (Emsley et al., 2010)
and PHENIX (Adams et al., 2010). Final statistics for the 2.3-A˚ resolution model
are given in Table S1. The accession number for the coordinates and structure-
factor amplitudes of Arl1GTP/DCBD51–71 is PDB: 5EE5. Identification of key res-
idues involved in Arl1GTP/DCBBIG1 interaction and DCBBIG1/DCBBIG1 were
based on results obtained from NCONT and CONTACT from CCP4 (Winn
et al., 2011). Figures were produced using PyMOL 1.7 and surface conserva-
tion assessed with ConSurf (Landau et al., 2005).
Fluorescence Anisotropy Experiments
The binding of DCB variants to Arl1, labeled with NT-495 (NanoTemper
Technologies), was measured by fluorescence anisotropy at 20C using a
PHERAstar plate-reader (BMG Labtech). The reaction was followed in
50 mM Tris-HCl (pH 8.0), 110 mM KCl, 1 mM DTT, 5 mM MgCl2, 0.001%
(v/v) Triton X-100, 0.1% (v/v) Tween-20, and 5 mM GTP. A control reaction
with free NT-495 label showed no change in anisotropy with increasing protein
concentration. Using a single-site binding model, the data were fitted to the
equation:
F =F0 +
ðF1 F0Þ ð½PT + ½LT+KdÞ  ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃð½PT + ½LT +KDÞ2 4½PT ½LTp 
2½PT  ;
where F0 and F1 are the anisotropy in the absence of titrating protein and at
saturation respectively, [LT] and [PT] are the total concentrations of DCBBIG1
and labeled Arl1GTP, and Kd is the dissociation constant. For all the mutant
DCB proteins, except K105A/Q201V, Q200E, and L156D, the value of F1
was fixed at the value fitted for the wild-type.
Circular Dichroism
Circular dichroism (CD) scans were recorded between 190 and 260 nm using a
JASCO-815 CD spectrophotometer at a protein concentration of 8 mM in PBS
at 20C. Control spectra of buffer were used to subtract the baseline contribu-
tion to the signals. Thermal denaturations were preformed over the range of848 Cell Reports 16, 839–850, July 19, 20164C to 95C at a rate of 1C/min. Data were fitted to a Boltzmann curve with
sloping baselines:
Yobs= ðY0N+aNTÞ+
"
ðY0N + bDTÞ  ðY0N+aNTÞ
1+ exp
ðTm  TÞ
C

#
;
where Yobs is the observed CD signal at temperature T; YN and YD are the
native and denatured protein CD contributions with aN and bD are the slopes
for the native and denatured signals, respectively; Tm is the melting tempera-
ture; and C is a constant. To compare protein stability of DCBBIG1 variants, CD
thermal denaturation data were transformed using the fitted baselines to the
CD scans data, and they were plotted as fraction of unfolded protein (fD) versus
temperature: Z
D=
Yobs ðY0N+aNTÞ
ðY0D+ bDTÞ  ðY0N+ aNTÞ:
SEC-MALS Analysis
MBP-tagged DCBBIG1 proteins were resolved on a Superdex-75 HR10/300
analytical gel filtration column (GE Healthcare) at 0.5 ml/min in PBS (pH 7.5),
150 mM NaCl, 5 mM MgCl2, and 0.001% (w/v) Triton X-100 before detection
on a Wyatt Heleos II 18 angle light-scattering instrument coupled to a Wyatt
Optilab rEX online refractive index detector and determination of native molec-
ular weight (Perica et al., 2014).
Binding Assays
GST-Arl1 (residues 15–181) and His6-tagged N-terminal fragments of human
BIG1, BIG2 (UniProt Q9Y6D5) and GBF1 (UniProt Q92538) were expressed
in BL21-CodonPlus (DE3)-RIPL cells and lysates prepared as described
above. His6-tagged proteins were purified using Ni-NTA beads (QIAGEN)
and GST-Arl1 using glutathione-Sepharose (GE Healthcare). Purified protein
were eluted and desalted in buffer C (20 mM Tris-HCl, 110 mM KCl, 0.1 mM
Mg2Cl, 1 mM DTT, and 0.1% Triton X-100). Purified GST-Arl1 was loaded
with nucleotide by incubation at 37C for 30 min in 10 mM EDTA and either
200 mM GMP-PNP or 1 mM GDP and then by increasing the MgCl2 to
20 mM and cooling to 4C. 2 nM GST-Arl1GMP-PNP or GST-Arl1GDP was mixed
with 2 nM of the His6-tagged protein in 500 ml buffer C plus 5 mM MgCl2 and
rotated at 4C for 30 min before adding 10 ml 50% glutathione-Sepharose
beads. Beads were washed thrice with 1 ml buffer C plus 5 mM MgCl2 and
bound material eluted with SDS buffer and analyzed by SDS-PAGE. 10 ml
Ni-NTA beads preloaded with His6-tagged DCB
BIG1 variants was mixed with
1 nM GST-Arl1GMP-PNP in 500 ml buffer C plus 5 mM Mg2Cl and 40 mM imid-
azole. Beads were washed thrice with 1 ml supplemented buffer C and bound
material eluted with 20 ml of SDS buffer and analyzed by SDS-PAGE.
Microscopic Imaging
HeLa Cells were transfected using FuGene 6 (Promega) and plated onto
multispot microscope slides 12 hr after transfection. Cell fixation, permeabili-
zation, staining, and confocal imaging (Zeiss LSM 780) were performed
as described previously (Wong and Munro, 2014). Live cell images were
acquired at 37C using a stage incubator and four-well chambers (Nunc
Lab-Tek) in media supplemented with fetal bovine serum and 20 mM HEPES
(pH 7.2).
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